Cancer Cachexia Market to Grow at a Substantial Growth Rate During the Forecast Period 2032, Estimates DelveInsight | Key Companies - AEterna Zentaris, Pfizer, Incyte, Smartfish AS, NGM Biopharmaceuticals, Caelus Health, Helsinn Therapeutics, Ono Pharma.,

DelveInsight's "Cancer Cachexia Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Cancer Cachexia Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Cancer Cachexia market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Cancer Cachexia: An Overview
Cancer cachexia is a wasting syndrome which is characterized by weight loss, anorexia (loss of desire to eat), asthenia and anaemia. The pathogenicity of this syndrome is multifactorial due to a complex interaction of tumour and host factors. It occurs in patients with advanced cancer, chronic obstructive pulmonary disease, chronic infection including AIDS and tuberculosis, chronic heart failure, and rheumatoid arthritis.

Cachexia can be treated by better managing symptoms that affect appetite, including nausea, pain and constipation. Treatments can attempt to stimulate the appetite with medications like synthetic hormones and corticosteroids.

Cancer Cachexia Market Key Facts
• As per a Japanese study conducted by Aoyagi et al., "Cancer cachexia, mechanism and treatment", cachexia occurs in most terminal cancer patients and is responsible for the death of 22% of cancer patients.
• According to the Cancer Cachexia Hub, approximately half of all patients with cancer experience cachexia. This rate of occurrence rises to as high as 86% in the last 1-2 weeks of life, with 45% of patients losing more than 10% of their original body weight over disease progression.
•As per DelveInsight, cancer cachexia affects both males and females equally.

Cancer Cachexia Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Cancer Cachexia market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Cancer Cachexia market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Request a sample and discover more about the report offerings:
https://www.delveinsight.com/report-store/cancer-cachexia-cc-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Cancer Cachexia Epidemiology
The epidemiology section covers detailed insights into the historical and current Cancer Cachexia patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

Cancer Cachexia Epidemiology Segmentation
• Incident/Prevalent Cases of Cancer Cachexia
• Diagnosed Cases of Cancer Cachexia
• Treatable Cases of Cancer Cachexia

Cancer Cachexia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cancer Cachexia market or expected to get launched in the market during the study period. The analysis covers Cancer Cachexia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Cancer Cachexia Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for a sample report to understand more about the Cancer Cachexia pipeline development activities:
https://www.delveinsight.com/report-store/cancer-cachexia-cc-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Cancer Cachexia Therapeutics Assessment
Currently, there are approx. 15+ key companies which are developing therapies for Cancer Cachexia. The companies with cancer cachexia drug candidates in the most advanced stage, i.e. Phase II, include AEterna Zentaris.

Some of the key companies in the Cancer Cachexia Market include:
• AEterna Zentaris
• Pfizer
• Incyte Corporation
• Smartfish AS
• NGM Biopharmaceuticals
• Caelus Health
• Helsinn Therapeutics/Ono Pharmaceutical
• Aphios Corporation
• Actimed Therapeutics
• Ildong Pharmaceutical
• Tetra Biopharma
• Aveo Oncology
And many others

Cancer Cachexia Therapies covered in the report include:
• Macimorelin (AEterna Zentaris)
• PF- 06946860 (Pfizer)
And many more

Learn more about the emerging therapies & key companies in the Cancer Cachexia Therapeutics Market:
https://www.delveinsight.com/sample-request/cancer-cachexia-cc-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Cancer Cachexia Competitive Intelligence Analysis
4. Cancer Cachexia Market Overview at a Glance
5. Cancer Cachexia Disease Background and Overview
6. Cancer Cachexia Patient Journey
7. Cancer Cachexia Epidemiology and Patient Population
8. Cancer Cachexia Treatment Algorithm, Current Treatment, and Medical Practices
9. Cancer Cachexia Unmet Needs
10. Key Endpoints of Cancer Cachexia Treatment
11. Cancer Cachexia Marketed Products
12. Cancer Cachexia Emerging Therapies
13. Cancer Cachexia Seven Major Market Analysis
14. Attribute Analysis
15. Cancer Cachexia Market Outlook (7 major markets)
16. Cancer Cachexia Access and Reimbursement Overview
17. KOL Views on the Cancer Cachexia Market.
18. Cancer Cachexia Market Drivers
19. Cancer Cachexia Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the Cancer Cachexia Market report here:
https://www.delveinsight.com/sample-request/cancer-cachexia-cc-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:
Anuj Rawat
Email: info@delveinsight.com
https://www.delveinsight.com/

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.